Securities abbreviation: Jiangsu Kanion Pharmaceutical Co.Ltd(600557) securities code: Jiangsu Kanion Pharmaceutical Co.Ltd(600557) Announcement No.: 2022007 Jiangsu Kanion Pharmaceutical Co.Ltd(600557)
Announcement on the resolutions of the 14th meeting of the 7th board of directors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents Jiangsu Kanion Pharmaceutical Co.Ltd(600557) (hereinafter referred to as “the company”) the notice of the 14th meeting of the seventh board of directors was sent by telephone and e-mail on February 18, 2022, and the meeting was held in the company’s conference room on March 2, 2022 in the combination of on-site and communication. There are 7 directors who should attend the meeting and 7 directors who actually attend the meeting. The meeting was held in accordance with the provisions of the company law, the articles of association and other laws and regulations. The meeting was presided over by Mr. Xiao Wei, chairman of the board of directors. The following proposals were considered and adopted by means of show of hands and communication voting, and a resolution was formed.
1、 The annual report for 2021 and its summary were considered and adopted
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s 2021 annual report and 2021 annual report summary disclosed.
Voting results: 7 in favor, 0 against and 0 abstention.
2、 The work report of the board of directors in 2021 was reviewed and adopted
The work report of the board of directors in 2021 is detailed in Section III “management discussion and analysis” of the company’s annual report in 2021.
Voting results: 7 in favor, 0 against and 0 abstention.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
3、 Reviewed and adopted the financial final accounts report of 2021
See section X “financial report” of the company’s 2021 annual report for the company’s 2021 annual report.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
4、 The profit distribution plan for 2021 was reviewed and approved
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s announcement of profit distribution plan for 2021 (Announcement No.: 2022009) disclosed.
Voting results: 7 in favor, 0 against and 0 abstention.
Independent directors have expressed their independent opinions on this proposal. See the company’s website www.sse.com on the same day for details com. cn. Independent opinions of independent directors on matters related to the 14th meeting of the seventh board of directors disclosed by the company.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
5、 The proposal on renewing the appointment of Lixin Certified Public Accountants (special general partnership) as the auditor of the company’s financial report in 2022 was reviewed and approved
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s announcement on renewing the appointment of accounting firms (Announcement No.: 2022010).
Voting results: 7 in favor, 0 against and 0 abstention.
The independent directors have issued their prior approval opinions and agreed independent opinions on this proposal. See the company’s website at www.sse.com on the same day com. cn. The disclosed company’s prior approval opinions on matters related to the 14th meeting of the seventh board of directors and independent opinions of independent directors on matters related to the 14th meeting of the seventh board of directors.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
6、 The proposal on reappointment of Lixin Certified Public Accountants (special general partnership) as the company’s internal control audit institution in 2022 was reviewed and approved
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s announcement on renewing the appointment of accounting firms (Announcement No.: 2022010).
Voting results: 7 in favor, 0 against and 0 abstention.
The independent directors have issued their prior approval opinions and agreed independent opinions on this proposal. See the company’s website at www.sse.com on the same day com. cn. The disclosed company’s prior approval opinions on matters related to the 14th meeting of the seventh board of directors and independent opinions of independent directors on matters related to the 14th meeting of the seventh board of directors.
This proposal shall be submitted to the 2021 annual general meeting of shareholders for deliberation.
7、 The proposal on daily connected transactions expected in 2022 was deliberated and adopted
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s announcement on expected daily connected transactions in 2022 (Announcement No.: 2022011).
When the board of Directors voted on this proposal, affiliated directors Mr. Xiao Wei, Mr. Wang Zhenzhong and Mr. Yang Yongchun avoided voting, and the other four directors (including three independent directors) participated in the voting.
Voting results: 4 in favor, 3 in avoidance, 0 against and 0 abstention.
The independent directors have issued their prior approval opinions and agreed independent opinions on this proposal. See the company’s website at www.sse.com on the same day com. cn. The disclosed company’s prior approval opinions on matters related to the 14th meeting of the seventh board of directors and independent opinions of independent directors on matters related to the 14th meeting of the seventh board of directors.
This proposal needs to be submitted to the 2021 annual general meeting of shareholders for deliberation, and related shareholders will avoid voting on this proposal. 8、 The 2021 internal control evaluation report was reviewed and adopted
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s 2021 internal control evaluation report disclosed.
Voting results: 7 in favor, 0 against and 0 abstention.
Independent directors have expressed their independent opinions on this proposal. See the company’s website www.sse.com on the same day for details com. cn. Independent opinions of independent directors on matters related to the 14th meeting of the seventh board of directors disclosed by the company.
9、 The 2021 corporate social responsibility report was reviewed and adopted
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s corporate social responsibility report in 2021 disclosed.
Voting results: 7 in favor, 0 against and 0 abstention.
10、 The proposal on appointing Mr. Gao Haixin as the deputy general manager of the company was deliberated and adopted
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s announcement on the appointment of senior managers and the change of securities affairs representative (Announcement No.: 2022012).
Independent directors have expressed their independent opinions on this proposal. See the company’s website www.sse.com on the same day for details com. cn. Independent opinions of independent directors on matters related to the 14th meeting of the seventh board of directors disclosed by the company.
Voting results: 7 in favor, 0 against and 0 abstention.
11、 The proposal on appointing Mr. Wang chuanlei as the deputy general manager of the company was deliberated and adopted
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s announcement on the appointment of senior managers and the change of securities affairs representative (Announcement No.: 2022012). Independent directors have expressed their independent opinions on this proposal. See the company’s website www.sse.com on the same day for details com. cn. Independent opinions of independent directors on matters related to the 14th meeting of the seventh board of directors disclosed by the company.
Voting results: 7 in favor, 0 against and 0 abstention.
12、 The proposal on appointing Mr. Pan Yu as the deputy general manager of the company was deliberated and adopted
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s announcement on the appointment of senior managers and the change of securities affairs representative (Announcement No.: 2022012). Independent directors have expressed their independent opinions on this proposal. See the company’s website www.sse.com on the same day for details com. cn. Independent opinions of independent directors on matters related to the 14th meeting of the seventh board of directors disclosed by the company.
Voting results: 7 in favor, 0 against and 0 abstention.
13、 The proposal on appointing Mr. Xiao Anliang as the chief financial officer of the company was deliberated and adopted
Announcement on appointment of senior managers and change of securities affairs representative (Announcement No.: 2022012). Independent directors have expressed their independent opinions on this proposal. See the company’s website www.sse.com on the same day for details com. cn. Independent opinions of independent directors on matters related to the 14th meeting of the seventh board of directors disclosed by the company.
Voting results: 7 in favor, 0 against and 0 abstention.
14、 The proposal on appointing Mr. Qiu Hongtao as the Secretary of the board of directors of the company was deliberated and adopted
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. The company’s announcement on the appointment of senior managers and the change of securities affairs representative (Announcement No.: 2022012). Independent directors have expressed their independent opinions on this proposal. See the company’s website www.sse.com on the same day for details com. cn. Independent opinions of independent directors on matters related to the 14th meeting of the seventh board of directors disclosed by the company.
Voting results: 7 in favor, 0 against and 0 abstention.
15、 The meeting heard the report on the work of independent directors in 2021
For details, please refer to the website of Shanghai Stock Exchange at www.sse.com on the same day com. cn. Report on the work of independent directors in 2021 disclosed by the company.
It is hereby announced.
Jiangsu Kanion Pharmaceutical Co.Ltd(600557) board of directors March 3, 2022
